X4 Pharmaceuticals Quote - XFOR

Professional-Grade Tools, for Individual Investors.

Premium

Current Price

0.19

Bid

0.22

Ask

0.20

Volume

1,826,662

0.1705 Day's Range 0.1921

0.1701 52 Week Range 1.29

Market Cap

32.996M

Previous Close

0.1872

Open

0.1773

Last Trade

1000

0.19

(formt)

Last Trade Time

Financial Volume

US$ 336,921

VWAP

0.184446

Average Volume (3m)

2,048,142

Shares Outstanding

173,662,376

Dividend Yield

PE Ratio

-0.88

Earnings Per Share (EPS)

-0.22

Revenue

107.56M

Net Profit

-37.45M

X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad ra... X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.x4pharma.com

Headquarters

Wilmington, Delaware, USA

Founded

X4 Pharmaceuticals Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker XFOR. The last closing price for X4 Pharmaceuticals was US$0.19. Over the last year, X4 Pharmaceuticals shares have traded in a share price range of US$ 0.1701 to US$ 1.29.

X4 Pharmaceuticals currently has 173,662,376 shares outstanding. The market capitalization of X4 Pharmaceuticals is US$32.51 million. X4 Pharmaceuticals has a price to earnings ratio (PE ratio) of -0.88.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.0008	-0.41928721174	0.1908	0.22	0.1701	1923790	0.19459612	CS
4	-0.0748	-28.247734139	0.2648	0.28	0.1701	1798192	0.21246109	CS
12	-0.46	-70.7692307692	0.65	0.81	0.1701	2048142	0.39902205	CS
26	-0.291	-60.498960499	0.481	0.8943	0.1701	3546867	0.51738943	CS
52	-1.1	-85.2713178295	1.29	1.29	0.1701	2712614	0.63431696	CS
156	-1.13	-85.6060606061	1.32	2.575	0.1701	2071641	1.01686725	CS
260	-9.33	-98.0042016807	9.52	11.11	0.1701	1341044	1.26470871	CS

XFOR - Frequently Asked Questions (FAQ)

What is the current X4 Pharmaceuticals share price?

The current share price of X4 Pharmaceuticals is US$ 0.19

How many X4 Pharmaceuticals shares are in issue?

X4 Pharmaceuticals has 173,662,376 shares in issue

What is the market cap of X4 Pharmaceuticals?

The market capitalisation of X4 Pharmaceuticals is USD 32.51M

What is the 1 year trading range for X4 Pharmaceuticals share price?

X4 Pharmaceuticals has traded in the range of US$ 0.1701 to US$ 1.29 during the past year

What is the PE ratio of X4 Pharmaceuticals?

The price to earnings ratio of X4 Pharmaceuticals is -0.88

What is the cash to sales ratio of X4 Pharmaceuticals?

The cash to sales ratio of X4 Pharmaceuticals is 0.31

What is the reporting currency for X4 Pharmaceuticals?

X4 Pharmaceuticals reports financial results in USD

What is the latest annual turnover for X4 Pharmaceuticals?

The latest annual turnover of X4 Pharmaceuticals is USD 107.56M

What is the latest annual profit for X4 Pharmaceuticals?

The latest annual profit of X4 Pharmaceuticals is USD -37.45M

What is the registered address of X4 Pharmaceuticals?

The registered address for X4 Pharmaceuticals is 3411 SILVERSIDE ROAD TATNALL, BUILDING #104, WILMINGTON, DELAWARE, 19810

What is the X4 Pharmaceuticals website address?

The website address for X4 Pharmaceuticals is www.x4pharma.com

Which industry sector does X4 Pharmaceuticals operate in?

X4 Pharmaceuticals operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
WWWW International Inc	US$ 0.395 (167.62%)	223.58M
OMEXOdyssey Marine Exploration Inc	US$ 1.4979 (75.79%)	285.65M
RTCBaijiayun Group Ltd	US$ 0.3244 (74.88%)	263.23M
GREEGreenidge Generation Holdings Inc	US$ 1.3197 (53.92%)	5.84M
SXTCChina SXT Pharmaceuticals Inc	US$ 2.28 (44.30%)	38.04M
CGTLCreative Global Technology Holdings Ltd	US$ 1.5197 (-75.09%)	3.88M
TOIIWOncology Institute Inc	US$ 0.1015 (-40.22%)	156.14k
COEPCoeptis Therapeutics Holdings Inc	US$ 7.70 (-38.25%)	716.99k
INTSIntesity Therapeutics Inc	US$ 0.56 (-37.78%)	3.21M
SMMTSummit Therapeutics Inc	US$ 23.47 (-36.05%)	24.67M
GNLNGreenlane Holdings Inc	US$ 0.012699 (-15.34%)	355.22M
AGMHAGM Group Holdings Inc	US$ 0.0477 (22.31%)	340.91M
OMEXOdyssey Marine Exploration Inc	US$ 1.4979 (75.79%)	285.65M
TSLLDirexion Daily TSLA Bull 2X Trust ETF	US$ 10.455 (19.62%)	266.95M
RTCBaijiayun Group Ltd	US$ 0.3244 (74.88%)	263.23M